This webinar will start at 18:00pm with the Welcome and Introductions. The first talk of the webinar will begin shortly after. Our expert speakers will be discussing the following topics:

  • Review of national framework clinical requirements, alignment to AF in PCN DES and IIF CVD05/06 & DPP
    • Major Bleed vs Minor Bleed
    • Side effects vs Red Flags
  • Initiating Anticoagulation how to guide, in depth detail of risk tools available to risk stratify
    • Bleed Risk including HASBLED and ORBIT
    • Renal Impairment and Hepatic Impairment
    • Increase monitoring or withholding anticoagulation
    • Falls? Interactions? Important Clinical considerations?
    • Extremes in Body Weight and Frailty
  • Switching from Warfarin to DOACs in line with NHSE guidance and EHRA guidance
  • Switching from DOAC to DOAC
  • Gastro-intestinal Protection and when this should be considered
    • What to consider and When?
  • Complications of when under-coagulated/over coagulated in AF?
  • Antiplatelet + Anticoagulation- Risk vs Benefit? What to consider
  • Monitoring Indices and Parameters- OTC, Herbal and NSAID’s- what is the data?

Our webinars are sponsored by the pharmaceutical industry. However, the agenda for each webinar is independently managed, and developed, by our clinical management team.

For any queries please contact magda@morphconsultancy.co.uk